Fertility and Sterility
Volume 94, Issue 1 , Pages 371-374, June 2010

Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes

  • Mehmet Murat Naki, M.D.

      Affiliations

    • Obstetrics and Gynecology Department, Dr. Lutfi Kirdar Kartal Research and Training Hospital, Kartal, Istanbul, Turkey
    • Corresponding Author InformationReprint requests: Dr. Mehmet Murat Naki, Cihat Saran Sok. Cagdas Ap. A Blok, No: 11/3, 34841 Kucukyali, Maltepe-Istanbul, Turkey (FAX: 90-216-441-51-62).
    • ,
  • Cevahir Tekcan, M.D.

      Affiliations

    • Obstetrics and Gynecology Department, Medipol Hospital, Kadikoy, Istanbul, Turkey
    • ,
  • Nahit Ozcan, M.D.

      Affiliations

    • Radiology Department, Sonomed Imaging Center, Kadikoy, Istanbul, Turkey
    • ,
  • Meliha Cebi, M.D.

      Affiliations

    • Radiology Department, Sonomed Imaging Center, Kadikoy, Istanbul, Turkey

Received 6 July 2009; received in revised form 23 September 2009; accepted 23 September 2009. published online 06 November 2009.

Levonorgestrel- (LNG) releasing intrauterine device (IUD) insertion revealed significant reduction in visual bleeding scores and spotting with an increase in amenorrhea and uterine pulsatility index scores. LNG-IUD can be considered as a simple and effective alternative to surgical treatment in the management of leiomyoma-dependent menorrhagia of reproductive-age women.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 M.M.N. has nothing to disclose. C.T. has nothing to disclose. N.O. has nothing to disclose. M.C. has nothing to disclose.

PII: S0015-0282(09)03798-4

doi:10.1016/j.fertnstert.2009.09.048

Fertility and Sterility
Volume 94, Issue 1 , Pages 371-374, June 2010

Article Tools